Quantifying TGFβ Release from LTBP1 Matrix
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Max Planck Institute of Biochemistry, King's College London, NYU Langone Health
Variable analysis
- Presence or absence of αvβ6 integrin blocking antibody (10D5; 20 μg ml−1; Chemicon)
- Presence or absence of TGFβ neutralizing antibody (1D11; 15 μg ml−1; BD Biosciences)
- Amount of released TGFβ
- Cell types (CHO LTBP1 cells, keratinocytes, tMLEC cells)
- Cell seeding densities (CHO LTBP1 cells: 5.0 × 104 cells per well, keratinocytes: 2.0 × 104 cells per well, tMLEC cells: 1.5 × 104 cells per well)
- Culture duration (48 h for CHO LTBP1 cells, 16-24 h for keratinocytes and tMLEC cells)
- Culture medium (not explicitly mentioned)
- Positive control: Keratinocytes and tMLEC cells cultured on LTBP1-TGFβ rich matrix without any blocking antibodies
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!